#China #Qingdao #Lab Equipment #Haier Biomedical #Biowissenschaften

Haier Biomedical's Remarkable Achievement in Global Market

Haier Biomedical, a prominent player in the global lab equipment market, recently made headlines by securing top rankings in Euromonitor International's "Global Life Science Lab Equipment Report". This recognition highlights the company's exceptional position as the number one brand among Chinese manufacturers in laboratory equipment for biosciences, along with being the number one in international sales within the same category. This double ranking not only signifies Haier Biomedical's remarkable growth but also emphasizes its commitment to quality and innovation in a competitive global market.

Accelerated Global Expansion

As the demand for advanced laboratory equipment increases worldwide, Haier Biomedical has executed a well-structured three-phase global expansion strategy. This approach has led the company to achieve an impressive average annual growth rate of over 20%. The strategic expansion process began with direct collaborations with international organizations such as UNICEF and the WHO. By addressing specific unmet needs, Haier Biomedical positioned itself as a leader in solar-powered vaccine storage solutions.

The company's distribution network currently spans across 160 countries with more than 800 active dealer relationships. This extensive reach has facilitated a rapid commencement of operational capabilities in critical regions. Their approach encompasses local warehousing, sales, marketing, product planning, and research and development allocations, ensuring they meet local demand effectively.

Specialized Expertise and Product Innovations

Haier Biomedical operates advanced research and development centers in the UK, Italy, and Japan, focusing on various product lines such as centrifuges, cold chain solutions, automated storage systems, incubators, and biosafety cabinets. Notably, specialized product professionals in the UK and mainland Europe provide on-site support, helping ensure compliance with Good Manufacturing Practices (GMP), air safety, and sample cleanliness. This specialized approach positions Haier Biomedical as a reliable partner in laboratory workflows.

The company’s commitment to top-notch service has led to the adoption of developed service standards in regions including the EU, South Asia, and Southeast Asia. Notably, Haier Biomedical has seen significant sales growth across various markets. In the first quarter of 2026, revenue climbed over 50% in Germany, Australia, and Canada, while Eastern Europe and Brazil reported remarkable growth exceeding 100% compared to the previous year. Sales of centrifuges and incubators doubled, underlining the rising demand for high-quality lab equipment.

Strategic Partnerships and Industry Recognition

Haier Biomedical has integrated into the supply chains of numerous leading pharmaceutical companies across prominent markets including Switzerland, Germany, Denmark, Italy, Singapore, the United States, Israel, and India. Additionally, the company’s Ultra Energy series has achieved top rankings in the US Energy-Star ratings, confirming its position as the best-selling line in its category.

Looking forward, Haier Biomedical is set to deepen investments in localization and increase its product diversity. The company aims to assist global biopharmaceutical and life science laboratories in enhancing their efficiency and sustainability. This strategy aligns with Haier Biomedical's overarching vision of becoming a global leader in providing integrated life science tools and intelligent productivity platforms.

For more information about Haier Biomedical and its innovative solutions, visit Haier Medical's official site.

Haier Biomedical’s recent achievements in the competitive global landscape exemplify not just innovation, but also a deep commitment to improving healthcare delivery worldwide through science and technology.